by Mark Chiang

马克·蒋

Share To

分享到

Ochsner Health has announced a partnership with Latent Health to integrate clinical artificial intelligence (AI) into its pharmacy operations. The collaboration aims to streamline the prior authorization process, enhance pharmacy efficiency, and improve patient access to medications.

奥克斯纳健康宣布与潜伏健康合作，将临床人工智能（AI）整合到其药房运营中。此次合作旨在简化事先授权流程、提高药房效率，并改善患者获取药物的途径。

According to details provided, the use of AI technology will focus on expediting the often time-consuming prior authorization procedures required for certain prescriptions. By automating aspects of this process, Ochsner Health seeks to reduce delays in medication approvals and ensure patients receive their treatments more quickly.

根据提供的详细信息，人工智能技术的使用将专注于加快某些处方所需的通常耗时的事先授权程序。通过自动化这一过程的各个方面，奥克斯纳健康中心力求减少药物审批的延迟，确保患者更快地获得治疗。

Additionally, the implementation of AI is expected to optimize overall pharmacy workflows, potentially allowing staff to allocate more time toward direct patient care. This initiative reflects ongoing efforts within healthcare systems to leverage advanced technologies in addressing operational challenges and improving service delivery..

此外，人工智能的实施有望优化药房的整体工作流程，使员工能够分配更多时间用于直接患者护理。这一举措反映了医疗系统正在不断努力利用先进技术来应对运营挑战并改善服务提供。

Newsflash | Powered by GeneOnline AI

新闻快讯 | 由GeneOnline AI提供支持

Source: GO-AI-ne1

来源：GO-AI-ne1

Date: July 25, 2025

日期：2025年7月25日

Related posts:

相关内容：

CDMO Partnerships Accelerate Drug Development, Freeing Internal Teams for Innovation.

CDMO 合作伙伴关系加速药物开发，让内部团队腾出时间进行创新。

European Council Advances New EU Rules to Reform Pharmaceutical Sector and Reduce Regulatory Burdens

欧盟理事会推进新欧盟规则以改革制药行业并减少监管负担

Calley Means Contributes to Presidential Commission Report on Chronic Diseases in Children

卡利·米恩斯为总统委员会关于儿童慢性疾病的报告做出了贡献。

Study Confirms Feasibility of Recording EEGs During Ambulance Transport Using BrainStatus Device

研究证实使用BrainStatus设备在救护车运输过程中记录脑电图的可行性

©www.geneonline.com All rights reserved. Collaborate with us:

©www.geneonline.com 版权所有。与我们合作：

[email protected]

[email protected]

Author

作者

Mark Chiang

蒋志祥

Related Post

相关内容

News Flash

新闻快讯

EMA Approves Propellant with 1000-Fold Lower Global Warming Potential for Trixeo and Riltrava Aerosphere

欧洲药品管理局批准了用于Trixeo和Riltrava Aerosphere的推进剂，其全球变暖潜能值降低了1000倍。

2025-07-25

2025年7月25日